Revelation Biosciences (REVB) Q2 2026 Earnings

7MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-20.64
-14.66
-8.69
-2.71

Details

Expected EPS
-2.71
Actual EPS
-2.71
Surprise EPS
0
Surprise Percent
+0%

Description

Revelation Biosciences (REVB) has reported earnings of -2.71 per share for Q2 2026.

0 Comments

Share your thoughts